Is a complete KRRO research report available?

No complete published report is available for Korro Bio, Inc. (KRRO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Korro Bio, Inc. (KRRO)

NASDAQ: KRRO · USD

$10.5

+0.38 (+3.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first KRRO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	150.7M
Revenue (ttm)	3.8M
Net income (ttm)	-113.5M
EPS (ttm)	-$11.4
Shares out	14.4M
Volume	129,677
Beta	2.11
Price target	$20.0	+91.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.8M
Net income (ttm): -113.5M
EPS (ttm): -$11.4
Market cap: 150.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All KRRO indicators

Market & fundamental data

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001703647
Company name	Korro Bio, Inc.
Country	United States
Country code	US
Cusip	500946108
Employees	49
Employees Change	-63%
Employees Change Percent	-56.25
Enterprise value	$36.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-03
Isin	US5009461089
Last refreshed	2026-07-31
Market cap	$150.7M
Market cap category	Micro-Cap
Price	$10.45
Price currency	USD
Rev Per Employee	78,408.16x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2834
Symbol	KRRO
Website	https://www.korrobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-75.31%
EV Sales Forward	36.55x
EV/Sales	9.51x
FCF yield	-46.85%
P/B ratio	1.26x
P/S ratio	39.23x
PS Forward	150.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3,052.34%
EBITDA Margin	-2,962.94%
Gross Profit	$-44.3M
Net Income	$-113.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-2,935.09%
Profit Per Employee	$-2.3M
ROA	-26.81
ROCE	-69.46
ROE	-87.78
ROIC	-29.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-31.09%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-20.31x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$183.6M
Cash	$114M
Current Assets	$120.2M
Current Liabilities	$14.8M
Debt	$42.9M
Debt Equity	$0.36
Equity	$119.6M
Interest Coverage	-161.3
Liabilities	$64M
Long Term Assets	$63.5M
Long Term Liabilities	$49.2M
Net Cash	$114.2M
Net Cash By Market Cap	$75.75
Net Cash Growth	21.71%
Net Debt Equity	$-0.95
Tangible Book Value	$119.6M
Tangible Book Value Per Share	$8.29
WACC	12.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.13
Net Working Capital	$-5.8M
Quick ratio	7.71
Working Capital	$105.4M
Working Capital Turnover	$0.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7.42%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-31.07%
200-day SMA	14.19
50-day SMA	12.16
50-day SMA vs 200-day SMA	50under200
All Time High	98
All Time High Change	-89.34%
All Time High Date	2024-10-16
All Time Low	5.2
All Time Low Change	100.81%
All Time Low Date	2025-12-02
ATR	0.97
Beta	2.11
Beta1y	2.99
Beta2y	2.92
Ch YTD	30.46
High	10.59
High52	55.89
High52 Date	2025-10-16
High52ch	-81.3%
Low	10
Low52	5.2
Low52 Date	2025-12-02
Low52ch	100.81%
Ma50ch	-14.09%
Price vs 200-day SMA	-26.34%
RSI	36.29
RSI Monthly	43.24
RSI Weekly	44.3
Sharpe ratio	0.65x
Sortino ratio	0.87
Total Return	-7.42%
Tr YTD	30.46
Tr1m	-20.8%
Tr1w	-9.37%
Tr3m	-17.13%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	11
Analyst Count Top	8
Analyst Price Target Top	$21.71
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.33
Earnings Revenue Estimate	433,336x
Earnings Revenue Estimate Growth	-70.32x
Operating Income	$-82.8M
Operating margin	-2,154
Price target	$20
Price Target Change	$91.39
Price Target Change Top	$108

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,531,486%
Float Percent	66.09%
Shares Insiders	4.79%
Shares Institutions	58.13%
Shares Out	14,422,571
Shares Qo Q	23.19%
Shares Yo Y	7.42%
Short Float	15.31%
Short Ratio	4.86
Short Shares	10.12

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-79.2M
Adjusted OCF	-78,808,000
Average Volume	197,678.45x
Bv Per Share	8.29
CAPEX	$-420,000
Ch1m	-20.8
Ch1w	-9.37
Ch1y	-31.07
Ch3m	-17.13
Ch6m	-21.49
Change	3.77%
Change From Open	1.85
Close	10.07
Days Gap	1.89
Depreciation Amortization	3,435,000
Dollar Volume	1,355,124.7
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-117.3M
EBITDA	$-113.8M
EPS	$-11.41
F Score	1
FCF	$-70.6M
FCF EV Yield	-193.18x
FCF Per Share	$-4.9
Financing CF	88,725,000
Fiscal Year End	December
Founded	2,014
Income Tax	$732,000
Investing CF	-21,028,000
Ipr	-25.36
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-12
Ma150	11.69
Ma150ch	-10.63%
Ma20	12.48
Ma20ch	-16.25%
Net CF	-2,447,000
Next Earnings Date	2026-08-11
Open	10.26
Optionable	Yes
Position In Range	76.27
Ppne	15,621,000
Price Date	2026-07-30
Ptbv Ratio	1.26
Relative Volume	0.66x
Revenue	3,842,000x
SBC By Revenue	224.49x
Share Based Comp	8,625,000
Tax By Revenue	19.05x
Tr6m	-21.49%
Us State	Massachusetts
Volume	129,677
Z Score	-2.25

Korro Bio, Inc. (KRRO)

Coverage state: Market snapshot only — no published research

Generate the first KRRO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · KRRO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KRRO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on KRRO

Frequently asked questions